Nucleotide sequence encoding a modulator of nf-kb
Abstract
The present invention relates to nucleotide sequences encoding a modulator of NF-κB, and to the polypeptides encoded by the nucleotide sequences. In particular, the invention relates to nucleotide sequences and the polypeptides encoded thereby, wherein the polypeptides are involved in the response to NF-κB-activating stimuli, including HTLV-1 Tax, LPS, PMA and IL-1. The invention also relates to antibodies to the modulator of NF-κB, methods of detecting modulator of NF-κB using the antibodies, methods of treatment associated with NF-κB activation and to methods of identifying compounds which modulate the activity of the modulator of NF-κB.
Claims
exact text as granted — not AI-modified1 - 50 . (canceled)
51 . A purified polypeptide, wherein the polypeptide is a modulator of NF-κB and has the following characteristics:
a) an apparent molecular weight of approximately 48 kD;
b) a pI of approximately 5.66;
c) containing a leucine zipper motif; and
d) binding to a kinase involved in the activation of NF-kB.
52 . The polypeptide of claim 51 , which is deficient in rat 5R cell and in murine pre-B cell line 1.3E2.
53 . The polypeptide of claim 51 , which is labeled with a detectable label.
54 . The polypeptide of claim 53 , wherein the label is selected from the group consisting of enzymes, chemicals which fluoresce and radioactive elements.
55 . A pharmaceutical composition comprising the polypeptide of claim 51 and a pharmaceutically acceptable carrier.
56 . A method for producing the polypeptide of claim 51 , comprising:
(a) culturing a unicellular host transformed with a recombinant DNA encoding the polypeptide; and (b) isolating the polypeptide from cultured unicellular host.
57 . The method of claim 56 , wherein the unicellular host is selected from group consisting of E. coli, Pseudomonas, Bacillus, Streptomyces , yeasts, CHO, R1.1, B-W, L-M, COS 1, COS 7, BSC1, BSC40, and BMT10 cells, plant cells, insect cells, and human cells in tissue culture.Join the waitlist — get patent alerts
Track US2011182811A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.